Find information on thousands of medical conditions and prescription drugs.

Detrol

Tolterodine (ATC code: G04BD) is an antimuscarinic drug that is used to treat urinary incontinence. It is sold under the trade name Detrol. more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Tolterodine acts on M2 and M3 subtypes of muscarinic receptors whereas most antimuscarinic treatments for overactive bladder only act on M3 receptors making them more selective. Tolterodine, however, although it acts on two types of receptors, has less side effects than other antimuscarinics eg. oxybutynin (which is selective for M3 only) as tolterodine targets the bladder more than other areas of the body. This means that less drug needs to be given daily (due to efficient targeting of the bladder) and so there are less side effects eg. hyposalivation, constipation, decreased gastric motility.

Read more at Wikipedia.org


[List your site here Free!]


Twice-Daily Detrol Effective for 2 Years
From Family Pratice News, 1/15/01 by Kate Johnson

HILTON HEAD ISLAND, S.C. -- Tolterodine tartrate given at a dosage of 2 mg twice daily for the treatment of overactive bladder maintains its efficacy over a 2-year period and becomes more tolerable with time, according to the results of a study of more than 700 patients.

"The incidence of adverse effects actually decreased over 2 years, and only 1.1% of patients withdrew because of dry mouth," study investigator Dr. Harold Drutz said at the annual meeting of the American Urogynecologic Society.

Until now the long-term safety and efficacy of tolterodine (Detrol) has not been documented. The study showed that there was an average 22% drop in daily micturition episodes and an 81% drop in daily incontinence episodes after 1 year of treatment. Those improvements were maintained over a second year of follow-up.

In addition, the incidence of side effects decreased from 79% in the first year to 71% in the second year, said Dr. Drutz, who is professor and head of the section of urogynecology at the University of Toronto.

The most common side effect reported was dry mouth, occurring at a rate of 36% in the first year and 19% in the second year.

A total of 80% of the patients completed the second year of treatment, with 6.5% withdrawing due to side effects and 13.5% withdrawing due to other reasons such as insufficient drug efficacy protocol violation, and consent withdrawal.

Among those who withdrew from the study eight. (1.1%) said they quit because of dry mouth, Dr. Drutz said at the meeting cosponsored by the American College of Obstetricians and Gynecologists.

The study was supported by a grant from the Pharmacia Corp., which markets the drug.

COPYRIGHT 2001 International Medical News Group
COPYRIGHT 2001 Gale Group

Return to Detrol
Home Contact Resources Exchange Links ebay